propofol has been researched along with Lymphoma, Non-Hodgkin in 1 studies
Propofol: An intravenous anesthetic agent which has the advantage of a very rapid onset after infusion or bolus injection plus a very short recovery period of a couple of minutes. (From Smith and Reynard, Textbook of Pharmacology, 1992, 1st ed, p206). Propofol has been used as ANTICONVULSANTS and ANTIEMETICS.
propofol : A phenol resulting from the formal substitution of the hydrogen at the 2 position of 1,3-diisopropylbenzene by a hydroxy group.
Lymphoma, Non-Hodgkin: Any of a group of malignant tumors of lymphoid tissue that differ from HODGKIN DISEASE, being more heterogeneous with respect to malignant cell lineage, clinical course, prognosis, and therapy. The only common feature among these tumors is the absence of giant REED-STERNBERG CELLS, a characteristic of Hodgkin's disease.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bassanezi, BS | 1 |
Oliveira-Filho, AG | 1 |
Miranda, ML | 1 |
Soares, L | 1 |
Aguiar, SS | 1 |
1 other study available for propofol and Lymphoma, Non-Hodgkin
Article | Year |
---|---|
Use of BiPAP for safe anesthesia in a child with a large anterior mediastinal mass.
Topics: Anesthesia, Conduction; Anesthetics, Intravenous; Anesthetics, Local; Biopsy; Child; Conscious Sedat | 2011 |